GRFS

AS OF

Nov 13, 04:59 PM (EDT)

Price

$8.69

Change

-$0.00 (-0.00%)

Capitalization

7.59B

105 days until earnings call

Intraday BUY SELL Signals

OUR PRODUCTS

MOBILE APPS

GENERAL INFO

Help

GRFS

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Grifols SA (GRFS) Earnings Date & Reports

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

GRFS is expected to report earnings to rise 68.07% to 35 cents per share on February 26

Q4'25

Est.

$0.35

Q3'25

Missed

by $0.03

Q2'25

Est.

$0.22

Q1'25

Missed

by $0.03

Q4'24

Beat

by $0.02

The last earnings report on November 04 showed earnings per share of 21 cents, missing the estimate of 24 cents. With 338.27K shares outstanding, the current market capitalization sits at 7.59B.

View a ticker or compare two or three

Compare

GRFS

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. GRFS showed earnings on November 04, 2025. You can read more about the earnings report here.

View AI-Driven Trading for GRFS

A.I. Advisor

published General Information

General Information

a manufacturer of plasma-derived biological medicines

Industry PharmaceuticalsMajor

Profile

Fundamentals

Details

Industry

Pharmaceuticals Major

Address

Avinguda de la Generalitat, 152

Phone

+34 935712200

Employees

23744

Web

https://www.grifols.com